Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECIGEN, INC. Director's Dealing 2022

Feb 4, 2022

32044_dirs_2022-02-04_c690c2d2-3cb1-4cb1-8d1d-199bc175f4e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2022-02-02

Reporting Person: Perez Jeffrey Thomas (SVP, IP Affairs)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-02 Option to Purchase Common Stock (Right to Buy) $2.33 A 150000 Acquired 2032-02-02 Common Stock (150000) Direct

Footnotes

F1: The option vests in four equal installments on each of February 2, 2023, February 2, 2024, February 2, 2025 and February 2, 2026.